Paloma Leiticia Martin Moreno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paloma Leiticia Martin Moreno has a total of 369 co-authors. Here are the top co-authors by number of shared publications:
- Nuria Garcia-Fernandez
Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain
11 shared publications Carlos Jiménez
Nephrology Department Hospital Universitario La Paz IdiPaz Madrid Spain
4 shared publications- Francesc Moreso
Department of Nephrology, Vall d'Hebron University Hospital, Barcelona, Spain
4 shared publications - Julio Pascual
Nephrology Department, Hospital del Mar, Barcelona, Spain
4 shared publications A. Andrés
Department of Nephrology, Hospital Universitario "12 de Octubre", Instituto de Investigación Hospital "12 de Octubre" (i+12), Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain
3 shared publicationsA. Mazuecos
Department of Nephrology, Hospital Universitario "Puerta del Mar", Cádiz, Spain
3 shared publications
Latest Publications
- Open Access
- 7 March 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (3) , e70501
Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once‐Daily Tacrolimus Formulations: The BITACORA Study
Introduction: Although advanced age is no longer a contraindication for renal transplantation, real‐world data on elderly transplant recipients remain limited. Methods: This multicenter, prospective study enrolled de novo kidney transplant recipients aged 60 years or older receiving once‐daily tacrolimus immunosuppression, following recovery of renal function and referral to the transplant clinic. The primary objective was to describe clinical characteristics and post‐transplant outcomes over a 12‐month follow‐up. Secondary objectives included assessing changes in quality of life and the relationship between biopsy‐proven acute rejection (BPAR) and tacrolimus levels. Results: Of 280 evaluable patients, 239 completed the 12‐month follow‐up (mean recipient age: 69.8 years; mean donor age: 69.1 years) and 41 (14.6%) terminated due to graft loss (13, 31.7%), tacrolimus termination (12, 29.3%), death (10, 24.4%), loss to follow‐up (3, 7.3%), other (2, 4.9%), and temporary tacrolimus interruption (1, 2.4%). BPAR occurred in 8.2% of patients who showed significantly higher tacrolimus levels vs those without BPAR over the follow‐up (9.8 ng/mL vs. 8.9 ng/mL; p = 0.01). Opportunistic infections were reported in 78.3% patients with BPAR vs 58.8% without BPAR ( p = 0.07). Quality of life improved across different domains of the Kidney Transplant Questionnaire and the ESRD‐SCL. Conclusion: This study monitored clinical outcomes during the first year post‐transplant in older de novo kidney transplant recipients receiving grafts from older donors and under a once‐daily tacrolimus‐based immunosuppressive regimen. The incidence of BPAR, graft loss, and mortality was low, and patients generally experienced an improvement in quality of life, indicating an effective and safe procedure in this population.
- 7 March 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (3) , e70501
Open AccessClinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once‐Daily Tacrolimus Formulations: The BITACORA Study
Introduction: Although advanced age is no longer a contraindication for renal transplantation, real‐world data on elderly transplant recipients remain limited. Methods: This multicenter, prospective study enrolled de novo kidney transplant recipients aged 60 years or older receiving once‐daily tacrolimus immunosuppression, following recovery of renal function and referral to the transplant clinic. The primary objective was to describe clinical characteristics and post‐transplant outcomes over a 12‐month follow‐up. Secondary objectives included assessing changes in quality of life and the relationship between biopsy‐proven acute rejection (BPAR) and tacrolimus levels. Results: Of 280 evaluable patients, 239 completed the 12‐month follow‐up (mean recipient age: 69.8 years; mean donor age: 69.1 years) and 41 (14.6%) terminated due to graft loss (13, 31.7%), tacrolimus termination (12, 29.3%), death (10, 24.4%), loss to follow‐up (3, 7.3%), other (2, 4.9%), and temporary tacrolimus interruption (1, 2.4%). BPAR occurred in 8.2% of patients who showed significantly higher tacrolimus levels vs those without BPAR over the follow‐up (9.8 ng/mL vs. 8.9 ng/mL; p = 0.01). Opportunistic infections were reported in 78.3% patients with BPAR vs 58.8% without BPAR ( p = 0.07). Quality of life improved across different domains of the Kidney Transplant Questionnaire and the ESRD‐SCL. Conclusion: This study monitored clinical outcomes during the first year post‐transplant in older de novo kidney transplant recipients receiving grafts from older donors and under a once‐daily tacrolimus‐based immunosuppressive regimen. The incidence of BPAR, graft loss, and mortality was low, and patients generally experienced an improvement in quality of life, indicating an effective and safe procedure in this population.
- Open Access
- 31 January 2025
- Published by Springer Nature in Neural Computing and Applications
- Vol. 37 (14) , 8347-8369
Advancing ASL kidney image registration: a tailored pipeline with VoxelMorph
In clinical renal assessment, image registration plays a pivotal role, as patient movement during data acquisition can significantly impede image post-processing and the accurate estimation of hemodynamic parameters. This study introduces a deep learning-based image registration framework specifically for arterial spin labeling (ASL) imaging. ASL is a magnetic resonance imaging technique that modifies the longitudinal magnetization of blood perfusing the kidney using a series of radiofrequency pulses combined with slice-selective gradients. After tagging the arterial blood, label images are captured following a delay, allowing the tagged blood bolus to enter the renal tissue, while control images are acquired without tagging the arterial spins. Given that perfusion maps are generated at the pixel level by subtracting control images from label images and considering the relatively small signal intensity difference, precise alignment of these images is crucial to minimize motion artefacts and prevent significant errors in perfusion calculations. Moreover, due to the extended ASL acquisition times and the anatomical location of the kidneys, renal images are often susceptible to pulsation, peristalsis, and breathing motion. These motion-induced noises and other instabilities can adversely affect ASL imaging outcomes, making image registration essential. However, research on renal MRI registration, particularly with respect to learning-based techniques, remains limited, with even less focus on renal ASL. Our study proposes a learning-based image registration approach that builds upon VoxelMorph and introduces groupwise inference as a key enhancement. The dataset includes 2448 images of transplanted kidneys (TK) and 2456 images of healthy kidneys (HK). We compared the automatic image registration results with the widely recognized optimization method Elastix. The model’s performance was evaluated using the mean structural similarity index (MSSIM), normalized correlation coefficient (NCC), temporal signal-to-noise ratio (TSNR) of the samples, and the mean cortical signal (CSIM) in perfusion-weighted images, thereby extending the evaluation beyond traditional similarity-based metrics. Our method achieved superior image registration performance, with peak NCC (0.987 ± 0.006) and MSSIM (0.869 ± 0.048) values in the kidney region, significantly surpassing Elastix and the unregistered series (p < 0.05) on TK and HK datasets. Regularization analysis showed that higher λ values (1, 2) produced smoother deformation fields, while moderate λ values (0.5, 0.9) balanced smoothness and detail, maintaining low non-positive Jacobian percentages (<1%) comparable to Elastix. Additionally, our method improved CSIM by 14.3% (2.304 ± 1.167) and TSNR by 13.1% (3.888 ± 2.170) in TK, and achieved up to 13.2% (CSIM) and 29.8% (TSNR) enhancements in HK, demonstrating robustness and improved signal quality across datasets and acquisition techniques.
- 31 January 2025
- Published by Springer Nature in Neural Computing and Applications
- Vol. 37 (14) , 8347-8369
Open AccessAdvancing ASL kidney image registration: a tailored pipeline with VoxelMorph
In clinical renal assessment, image registration plays a pivotal role, as patient movement during data acquisition can significantly impede image post-processing and the accurate estimation of hemodynamic parameters. This study introduces a deep learning-based image registration framework specifically for arterial spin labeling (ASL) imaging. ASL is a magnetic resonance imaging technique that modifies the longitudinal magnetization of blood perfusing the kidney using a series of radiofrequency pulses combined with slice-selective gradients. After tagging the arterial blood, label images are captured following a delay, allowing the tagged blood bolus to enter the renal tissue, while control images are acquired without tagging the arterial spins. Given that perfusion maps are generated at the pixel level by subtracting control images from label images and considering the relatively small signal intensity difference, precise alignment of these images is crucial to minimize motion artefacts and prevent significant errors in perfusion calculations. Moreover, due to the extended ASL acquisition times and the anatomical location of the kidneys, renal images are often susceptible to pulsation, peristalsis, and breathing motion. These motion-induced noises and other instabilities can adversely affect ASL imaging outcomes, making image registration essential. However, research on renal MRI registration, particularly with respect to learning-based techniques, remains limited, with even less focus on renal ASL. Our study proposes a learning-based image registration approach that builds upon VoxelMorph and introduces groupwise inference as a key enhancement. The dataset includes 2448 images of transplanted kidneys (TK) and 2456 images of healthy kidneys (HK). We compared the automatic image registration results with the widely recognized optimization method Elastix. The model’s performance was evaluated using the mean structural similarity index (MSSIM), normalized correlation coefficient (NCC), temporal signal-to-noise ratio (TSNR) of the samples, and the mean cortical signal (CSIM) in perfusion-weighted images, thereby extending the evaluation beyond traditional similarity-based metrics. Our method achieved superior image registration performance, with peak NCC (0.987 ± 0.006) and MSSIM (0.869 ± 0.048) values in the kidney region, significantly surpassing Elastix and the unregistered series (p < 0.05) on TK and HK datasets. Regularization analysis showed that higher λ values (1, 2) produced smoother deformation fields, while moderate λ values (0.5, 0.9) balanced smoothness and detail, maintaining low non-positive Jacobian percentages (<1%) comparable to Elastix. Additionally, our method improved CSIM by 14.3% (2.304 ± 1.167) and TSNR by 13.1% (3.888 ± 2.170) in TK, and achieved up to 13.2% (CSIM) and 29.8% (TSNR) enhancements in HK, demonstrating robustness and improved signal quality across datasets and acquisition techniques.
- Open Access
- 5 August 2024
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 47 (2)
Biomarkers of oxidative stress and inflammation in contrast-associated acute kidney injury
Iodinated contrast-induced acute kidney injury (CI-AKI) is a common cause of renal failure, especially in patients with risk factors. This study analyses different renal biomarkers in patients undergoing computed tomography scans with iodinated contrast to identify the molecular and cellular mechanisms involved in the pathogenesis of CI-AKI. Prospective study that included patients with high risk of renal disease who received iodinated contrast (iohexol) for the computed tomography scans. Functional biomarkers (creatinine and cystatin C), inflammatory and oxidative stress markers (neutrophil gelatinase-associated lipocalin [NGAL], interleukin-8 [IL-8], superoxide dismutase [SOD], F2-isoprostanes, and cardiotrophin-1), and cell cycle biomarkers (Nephrocheck®) were analysed before the iodinated contrast and 4, 12, 24, and 48 hours post-contrast, in relation to the incidence of IC-AKI. IC-AKI was observed in 30.6% of the 62 study participants and in 57.1% of the patients with diabetes and renal dysfunction. Factors associated with IC-AKI were a higher mean age (74.4 vs 64.9 years), pre-existing renal dysfunction (60 vs 16.7%), and higher adjusted mean volume of iohexol (42.9 vs 32.1%). As for non-functional biomarkers. No differences were found between patients with and without CI-AKI. The use of iodinated contrast was associated with a decrease in SOD antioxidant activity at 4 hours and an increase in IL-8 at 12 hours post-administration of the iodinated contrast. Administration of iohexol in computed tomography scans in patients with high risk of renal disease results in an elevated percentage of CI-AKI, attributable to ischemia/reperfusion injury and/or direct toxicity of the iodinated contrast.
- 5 August 2024
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 47 (2)
Open AccessBiomarkers of oxidative stress and inflammation in contrast-associated acute kidney injury
Iodinated contrast-induced acute kidney injury (CI-AKI) is a common cause of renal failure, especially in patients with risk factors. This study analyses different renal biomarkers in patients undergoing computed tomography scans with iodinated contrast to identify the molecular and cellular mechanisms involved in the pathogenesis of CI-AKI. Prospective study that included patients with high risk of renal disease who received iodinated contrast (iohexol) for the computed tomography scans. Functional biomarkers (creatinine and cystatin C), inflammatory and oxidative stress markers (neutrophil gelatinase-associated lipocalin [NGAL], interleukin-8 [IL-8], superoxide dismutase [SOD], F2-isoprostanes, and cardiotrophin-1), and cell cycle biomarkers (Nephrocheck®) were analysed before the iodinated contrast and 4, 12, 24, and 48 hours post-contrast, in relation to the incidence of IC-AKI. IC-AKI was observed in 30.6% of the 62 study participants and in 57.1% of the patients with diabetes and renal dysfunction. Factors associated with IC-AKI were a higher mean age (74.4 vs 64.9 years), pre-existing renal dysfunction (60 vs 16.7%), and higher adjusted mean volume of iohexol (42.9 vs 32.1%). As for non-functional biomarkers. No differences were found between patients with and without CI-AKI. The use of iodinated contrast was associated with a decrease in SOD antioxidant activity at 4 hours and an increase in IL-8 at 12 hours post-administration of the iodinated contrast. Administration of iohexol in computed tomography scans in patients with high risk of renal disease results in an elevated percentage of CI-AKI, attributable to ischemia/reperfusion injury and/or direct toxicity of the iodinated contrast.
- Open Access
- 19 January 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 60 (4) , 1650-1663
Diagnostic and Prognostic Potential of Multiparametric Renal MRI in Kidney Transplant Patients
Background: Multiparametric MRI provides assessment of functional and structural parameters in kidney allografts. It offers a non‐invasive alternative to the current reference standard of kidney biopsy.Purpose: To evaluate the diagnostic and prognostic utility of MRI parameters in the assessment of allograft function in the first 3‐months post‐transplantation.Study Type: Prospective.Subjects: 32 transplant recipients (54 ± 17 years, 20 females), divided into two groups according to estimated glomerular filtration rate (eGFR) at 3‐months post‐transplantation: inferior graft function (IGF; eGFR2, n = 10) and superior graft function (SGF; eGFR ≥ 45 mL/min/1.73 m2, n = 22). Further categorization was based on the need for hemodialysis (C1) and decrease in s‐creatinine (C2) at 1‐week post‐transplantation: delayed‐graft‐function (DGF: n = 4 C1, n = 10 C2) and early graft‐function (EGF: n = 28 C1, n = 22 C2).Field Strength/Sequence: 3‐T, pseudo‐continuous arterial spin labeling, T1‐mapping, and diffusion‐weighted imaging.Assessment: Multiparametric MRI was evaluated at 1‐week in all patients and 3‐months after transplantation in 28 patients. Renal blood flow (RBF), diffusion coefficients (ADC, ΔADC, D, D, D*, flowing fraction f), T1 and T1 were calculated in cortex and medulla. The diagnostic and prognostic value of these parameters, obtained at 3‐months and 1‐week post‐transplantation, respectively, was evaluated in the cortex to discriminate between DGF and EGF, and between SGF and IGF.Statistical Tests: Logistic regression, receiver‐operating‐characteristics, area‐under‐the‐curve (AUC), confidence intervals (CIs), analysis‐of‐variance, t‐test, Wilcoxon‐Mann–Whitney test, Fisher's exact test, Pearson's correlation. P‐valueD*. The diagnostic value of MRI for detecting DGF was excellent (AUC = 100%). Significant differences between patients with IGF and SGF were found in RBF, ∆T1, and ∆D. Multiparametric MRI showed higher diagnostic (AUC = 95.32%; CI: 88%–100%) and prognostic (AUC = 97.47%, CI: 92%–100%) values for detecting IGF than eGFR (AUC = 89.50%, CI: 79%–100%).Data Conclusion: Multiparametric MRI may show high diagnostic and prognostic value in transplanted patients, yielding better results compared to eGFR measurements.Level of Evidence: 2Technical Efficacy: Stage 1
- 19 January 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 60 (4) , 1650-1663
Open AccessDiagnostic and Prognostic Potential of Multiparametric Renal MRI in Kidney Transplant Patients
Background: Multiparametric MRI provides assessment of functional and structural parameters in kidney allografts. It offers a non‐invasive alternative to the current reference standard of kidney biopsy.Purpose: To evaluate the diagnostic and prognostic utility of MRI parameters in the assessment of allograft function in the first 3‐months post‐transplantation.Study Type: Prospective.Subjects: 32 transplant recipients (54 ± 17 years, 20 females), divided into two groups according to estimated glomerular filtration rate (eGFR) at 3‐months post‐transplantation: inferior graft function (IGF; eGFR2, n = 10) and superior graft function (SGF; eGFR ≥ 45 mL/min/1.73 m2, n = 22). Further categorization was based on the need for hemodialysis (C1) and decrease in s‐creatinine (C2) at 1‐week post‐transplantation: delayed‐graft‐function (DGF: n = 4 C1, n = 10 C2) and early graft‐function (EGF: n = 28 C1, n = 22 C2).Field Strength/Sequence: 3‐T, pseudo‐continuous arterial spin labeling, T1‐mapping, and diffusion‐weighted imaging.Assessment: Multiparametric MRI was evaluated at 1‐week in all patients and 3‐months after transplantation in 28 patients. Renal blood flow (RBF), diffusion coefficients (ADC, ΔADC, D, D, D*, flowing fraction f), T1 and T1 were calculated in cortex and medulla. The diagnostic and prognostic value of these parameters, obtained at 3‐months and 1‐week post‐transplantation, respectively, was evaluated in the cortex to discriminate between DGF and EGF, and between SGF and IGF.Statistical Tests: Logistic regression, receiver‐operating‐characteristics, area‐under‐the‐curve (AUC), confidence intervals (CIs), analysis‐of‐variance, t‐test, Wilcoxon‐Mann–Whitney test, Fisher's exact test, Pearson's correlation. P‐valueD*. The diagnostic value of MRI for detecting DGF was excellent (AUC = 100%). Significant differences between patients with IGF and SGF were found in RBF, ∆T1, and ∆D. Multiparametric MRI showed higher diagnostic (AUC = 95.32%; CI: 88%–100%) and prognostic (AUC = 97.47%, CI: 92%–100%) values for detecting IGF than eGFR (AUC = 89.50%, CI: 79%–100%).Data Conclusion: Multiparametric MRI may show high diagnostic and prognostic value in transplanted patients, yielding better results compared to eGFR measurements.Level of Evidence: 2Technical Efficacy: Stage 1
- Open Access
- 28 September 2023
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 104, 39-51
A deep learning image analysis method for renal perfusion estimation in pseudo-continuous arterial spin labelling MRI
- 28 September 2023
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 104, 39-51
Open AccessA deep learning image analysis method for renal perfusion estimation in pseudo-continuous arterial spin labelling MRI
- Open Access
- 1 January 2022
- Published by Elsevier in Nefrología
- Vol. 42 (1) , 85-93
Trasplante renal de donante vivo. Análisis de situación y hoja de ruta
- 1 January 2022
- Published by Elsevier in Nefrología
- Vol. 42 (1) , 85-93
Open AccessTrasplante renal de donante vivo. Análisis de situación y hoja de ruta
- Open Access
- 5 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (11) , 2497
Obesity and Post-Transplant Diabetes Mellitus in Kidney Transplantation
Worldwide, the prevalence obesity, diabetes, and chronic kidney disease is increasing apace. The relationship between obesity and chronic kidney disease is multidimensional, especially when diabetes is also considered. The optimal treatment of patients with chronic kidney disease includes the need to consider weight loss as part of the treatment. The exact relationship between obesity and kidney function before and after transplantation is not as clear as previously imagined. Historically, patients with obesity had worse outcomes following kidney transplantation and weight loss before surgery was encouraged. However, recent studies have found less of a correlation between obesity and transplant outcomes. Transplantation itself is also a risk factor for developing diabetes, a condition known as post-transplant diabetes mellitus, and is related to the use of immunosuppressive medications and weight gain following transplantation. Newer classes of anti-diabetic medications, namely SGLT-2 inhibitors and GLP-1 agonists, are increasingly being recognized, not only for their ability to control diabetes, but also for their cardio and renoprotective effects. This article reviews the current state of knowledge on the management of obesity and post-transplant diabetes mellitus for kidney transplant patients.
- 5 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (11) , 2497
Open AccessObesity and Post-Transplant Diabetes Mellitus in Kidney Transplantation
Worldwide, the prevalence obesity, diabetes, and chronic kidney disease is increasing apace. The relationship between obesity and chronic kidney disease is multidimensional, especially when diabetes is also considered. The optimal treatment of patients with chronic kidney disease includes the need to consider weight loss as part of the treatment. The exact relationship between obesity and kidney function before and after transplantation is not as clear as previously imagined. Historically, patients with obesity had worse outcomes following kidney transplantation and weight loss before surgery was encouraged. However, recent studies have found less of a correlation between obesity and transplant outcomes. Transplantation itself is also a risk factor for developing diabetes, a condition known as post-transplant diabetes mellitus, and is related to the use of immunosuppressive medications and weight gain following transplantation. Newer classes of anti-diabetic medications, namely SGLT-2 inhibitors and GLP-1 agonists, are increasingly being recognized, not only for their ability to control diabetes, but also for their cardio and renoprotective effects. This article reviews the current state of knowledge on the management of obesity and post-transplant diabetes mellitus for kidney transplant patients.
- 17 February 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (5) , e14256
Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study
Background: The use of mycophenolic acid (MPA) in women during pregnancy causes an increase in miscarriages and birth defects with a typical embryopathy profile. Although epidemiological data does not suggest a greater risk among the offspring of male kidney transplant recipients, the European Medicines Agency and The Spanish Agency of Medicines and Medical Devices introduced the recommendation of using contraceptive methods.Methods: We conducted a national retrospective study in 15 Spanish Kidney Transplant Centers to evaluate the frequency of miscarriages and birth defects between the offspring from male kidney transplants recipients. We included 151 males who had fathered 239 offspring, 225 under MPA and 14 without MPA.Results: The results of our study showed an incidence of miscarriages in the MPA group of 9.8%, and of birth defects of 4%.Conclusions: We observed an incidence of miscarriages between the offspring fathered by kidney transplant males under MPA lower than the general population. The incidence of birth defects was similar to the incidence described in other studies and the fact that we did not find the typical embryopathy profile makes it difficult to associate them to the use of MPA. Because of that, we urge the European and Spanish Agencies to reconsider their recommendations for males.
- 17 February 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (5) , e14256
Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study
Background: The use of mycophenolic acid (MPA) in women during pregnancy causes an increase in miscarriages and birth defects with a typical embryopathy profile. Although epidemiological data does not suggest a greater risk among the offspring of male kidney transplant recipients, the European Medicines Agency and The Spanish Agency of Medicines and Medical Devices introduced the recommendation of using contraceptive methods.Methods: We conducted a national retrospective study in 15 Spanish Kidney Transplant Centers to evaluate the frequency of miscarriages and birth defects between the offspring from male kidney transplants recipients. We included 151 males who had fathered 239 offspring, 225 under MPA and 14 without MPA.Results: The results of our study showed an incidence of miscarriages in the MPA group of 9.8%, and of birth defects of 4%.Conclusions: We observed an incidence of miscarriages between the offspring fathered by kidney transplant males under MPA lower than the general population. The incidence of birth defects was similar to the incidence described in other studies and the fact that we did not find the typical embryopathy profile makes it difficult to associate them to the use of MPA. Because of that, we urge the European and Spanish Agencies to reconsider their recommendations for males.
- Open Access
- 12 July 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3182-3190
Use of tocilizumab in kidney transplant recipients with COVID-19
- 12 July 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3182-3190
Open AccessUse of tocilizumab in kidney transplant recipients with COVID-19
- Open Access
- 1 May 2020
- Published by Elsevier in Nefrología
- Vol. 40 (3) , 223-236
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
- 1 May 2020
- Published by Elsevier in Nefrología
- Vol. 40 (3) , 223-236
Open AccessBurden and challenges of heart failure in patients with chronic kidney disease. A call to action